Date Range
Date Range
Date Range
Company MorphoSys in a Nutshell. Science Engineering the Medicines of Tomorrow. Discovery, Alliances and Technologies. Disease biology and target validation. Drug profiling and assay development. Partnering MorphoSys as a Partner.
Wissenschaft Engineering the Medicines of Tomorrow. Discovery, Alliances and Technologies. Herstellung, Chemie- und Produktionskontrolle. Medien und Investoren Investition in die Medikamente von morgen. Um das Leben schwerkranker Menschen.
Collaboration, innovation and achieving results that impact the lives of people in need. We are a team of respectful and caring professionals working together with the best and brightest in our industry to find new ways to bring hope, and ultimately a solution, for some of the toughest challenges in medicine. Morphotek Announces Agreement to License its Proprietary Eribulin. Morphotek to Present Poster on CA125 Suppression of Humoral Immune. Morphotek Announces FDA Acceptance of Investigational New Drug.
Les costumes et décors en latex, silicones, mousses et polyester.